Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Sale of 3,377 DFTX shares, $123.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 3,377 | $123.5K |
| Sep 14, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 125,000 | n/a |
| Aug 12, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Jun 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 3,013 | $135.7K |
| Jun 22, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Feb 5, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 150,000 | n/a |
| Jun 2, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/Award | 500,000 | n/a |
| Oct 29, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/Award | 7,900 | n/a |
| Apr 22, 2024 | TFF Pharmaceuticals, Inc. (TFFP) | Grant/Award | 5,333 | n/a |
| Feb 9, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/Award | 15,090 | n/a |